ArticleNeuro-oncology2026

Transcriptomics-guided high-throughput drug screening identifies potent therapies for P53 pathway altered DIPG/DMG.

Zhuang Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.